Rohan Bareja

4.7k total citations · 2 hit papers
42 papers, 1.4k citations indexed

About

Rohan Bareja is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Rohan Bareja has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Rohan Bareja's work include Prostate Cancer Treatment and Research (12 papers), Cancer Genomics and Diagnostics (5 papers) and Glioma Diagnosis and Treatment (4 papers). Rohan Bareja is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Cancer Genomics and Diagnostics (5 papers) and Glioma Diagnosis and Treatment (4 papers). Rohan Bareja collaborates with scholars based in United States, Israel and Italy. Rohan Bareja's co-authors include Andrea Sboner, Himisha Beltran, Olivier Elemento, Mark A. Rubin, Vincenza Conteduca, Diana G. Wang, Siddhartha Mukherjee, David Wu, Xiang Li and Benjamin D. Hopkins and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Rohan Bareja

41 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

2018 481 citations Rohan Bareja, Andrea Sboner et al. profile →
Clinical features of neuroendocrine prostate cancer

2019 232 citations Vincenza Conteduca, Clara Oromendia et al. European Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rohan Bareja United States	15	824	517	390	362	167	42	1.4k
Shulin Wu United States	23	670 0.8×	691 1.3×	419 1.1×	342 0.9×	75 0.4×	63	1.6k
Mónica Garcı́a-Barros United States	15	1.0k 1.2×	441 0.9×	470 1.2×	419 1.2×	128 0.8×	21	2.0k
Emmanuel Martínez-Ledesma United States	14	1.0k 1.2×	314 0.6×	460 1.2×	341 0.9×	257 1.5×	34	1.6k
Hisashi Hasumi Japan	20	700 0.8×	697 1.3×	213 0.5×	173 0.5×	187 1.1×	73	1.4k
Lyndon Kim United States	19	756 0.9×	633 1.2×	554 1.4×	412 1.1×	139 0.8×	42	2.4k
Kenneth Aldape United States	13	1.2k 1.4×	347 0.7×	686 1.8×	557 1.5×	60 0.4×	32	1.9k
Bing Liao China	22	670 0.8×	301 0.6×	444 1.1×	371 1.0×	167 1.0×	71	1.9k
Robert S. Seitz United States	21	875 1.1×	396 0.8×	461 1.2×	493 1.4×	138 0.8×	42	1.8k
Scott M. Welford United States	24	1.6k 2.0×	671 1.3×	1.2k 3.0×	418 1.2×	149 0.9×	60	2.6k
Anuj Goenka United States	13	933 1.1×	478 0.9×	760 1.9×	198 0.5×	47 0.3×	40	2.0k

Countries citing papers authored by Rohan Bareja

Since Specialization

Citations

This map shows the geographic impact of Rohan Bareja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohan Bareja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohan Bareja more than expected).

Fields of papers citing papers by Rohan Bareja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rohan Bareja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohan Bareja. The network helps show where Rohan Bareja may publish in the future.

Co-authorship network of co-authors of Rohan Bareja

This figure shows the co-authorship network connecting the top 25 collaborators of Rohan Bareja. A scholar is included among the top collaborators of Rohan Bareja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rohan Bareja. Rohan Bareja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yağmurlu, Banu, et al.. (2025). Brain tumor segmentation using deep learning: high performance with minimized MRI data. PubMed. 5. 1616293–1616293. 1 indexed citations

Barba, Thomas, et al.. (2025). Integration of MRI radiomics and germline genetics to predict the IDH mutation status of gliomas. npj Precision Oncology. 9(1). 187–187. 3 indexed citations

Bareja, Rohan, Marwa Ismail, Douglas Martin, et al.. (2024). nnU-Net–based Segmentation of Tumor Subcompartments in Pediatric Medulloblastoma Using Multiparametric MRI: A Multi-institutional Study. Radiology Artificial Intelligence. 6(5). e230115–e230115. 4 indexed citations

Bhinder, Bhavneet, Alison Ferguson, Michael Sigouros, et al.. (2023). Immunogenomic Landscape of Neuroendocrine Prostate Cancer. Clinical Cancer Research. 29(15). 2933–2943. 19 indexed citations

Eljalby, Mahmoud, Rohan Bareja, Wanhong Ding, et al.. (2023). Soluble adenylyl cyclase contributes to imiquimod‐mediated inflammation and is a potential therapeutic target in psoriasis. Experimental Dermatology. 32(7). 1051–1062. 1 indexed citations

Gopal, Priyanka, Aaron Petty, Kevin Rogacki, et al.. (2022). Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma. Science Advances. 8(50). eabp8674–eabp8674. 10 indexed citations

Cyrta, Joanna, Joel Rosiene, Rohan Bareja, et al.. (2022). Whole-genome characterization of myoepithelial carcinomas of the soft tissue. Molecular Case Studies. 8(7). a006227–a006227. 2 indexed citations

Brady, Nicholas J., Richa Singh, Vincenza Conteduca, et al.. (2021). Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer. Nature Communications. 12(1). 3372–3372. 50 indexed citations

Sfakianos, John P., Jorge Daza, Yang Hu, et al.. (2020). Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers. Nature Communications. 11(1). 2540–2540. 40 indexed citations

10.

Auguste, Aurélie, Félix Blanc‐Durand, Marc Deloger, et al.. (2020). Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis. Cells. 9(6). 1496–1496. 31 indexed citations

11.

Conteduca, Vincenza, Sheng‐Yu Ku, Loredana Puca, et al.. (2020). SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy. Molecular Cancer Therapeutics. 19(5). 1157–1164. 46 indexed citations

12.

Fragliasso, Valentina, Akanksha Verma, Gloria Manzotti, et al.. (2020). The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK− anaplastic large cell lymphoma by regulating the DNA helicase HELLS. Leukemia. 34(11). 2964–2980. 11 indexed citations

13.

Conteduca, Vincenza, Clara Oromendia, Kenneth Eng, et al.. (2019). Clinical features of neuroendocrine prostate cancer. European Journal of Cancer. 121. 7–18. 232 indexed citations breakdown →

14.

Bareja, Rohan, Panagiotis J. Vlachostergios, Brian D. Robinson, et al.. (2019). Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer. Journal of the National Comprehensive Cancer Network. 17(3). 194–200. 6 indexed citations

15.

Berger, Adeline, Nicholas J. Brady, Rohan Bareja, et al.. (2019). N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer. Journal of Clinical Investigation. 129(9). 3924–3940. 116 indexed citations

16.

Cai, Ling, Yi‐Hsuan Tsai, Ping Wang, et al.. (2018). ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Molecular Cell. 72(2). 341–354.e6. 64 indexed citations

17.

Mottahedeh, Jack, Michael C. Haffner, Tristan Grogan, et al.. (2018). CD38 is methylated in prostate cancer and regulates extracellular NAD+. SHILAP Revista de lepidopterología. 6(1). 13–13. 29 indexed citations

18.

Berk, Michael, Yoon-Mi Chung, Belinda Willard, et al.. (2018). Loss of an Androgen-Inactivating and Isoform-Specific HSD17B4 Splice Form Enables Emergence of Castration-Resistant Prostate Cancer. Cell Reports. 22(3). 809–819. 31 indexed citations

19.

Anelli, Viviana, Jacques A. Villefranc, Sagar Chhangawala, et al.. (2017). Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression. eLife. 6. 47 indexed citations

20.

Danila, Daniel C., Bruce Montgomery, Russell Z. Szmulewitz, et al.. (2016). A phase 2 study of the aurora kinase A inhibitor alisertib for patients with neuroendocrine prostate cancer (NEPC). Annals of Oncology. 27. vi565–vi565. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact